UCMOK
GMAB icon

United Capital Management of KS’s Genmab GMAB Stock Holding History

United Capital Management of KS’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,000
Closed -$370K – 106
2026
Q1 		$370K Buy
12,000
+3,000
+33% +$89.9K 0.06% 91
2025
Q4 		$277K Buy
+9,000
New +$281K 0.04% 100

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

United Capital Management of KS's GMAB Position: Q2 2026 in Review

United Capital Management of KS sold out of Genmab (GMAB) in Q2 2026, closing a stake of 12,000 shares — an estimated $370K sold.

United Capital Management of KS first reported a position in GMAB in Q4 2025 and held it in 2 quarters. The position peaked at $370K in Q1 2026. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • United Capital Management of KS reported no remaining Genmab position as of Q2 2026 after selling out during the quarter.
  • United Capital Management of KS sold 12,000 Genmab shares in Q2 2026, an estimated $370K.
  • United Capital Management of KS first reported a position in Genmab in Q4 2025 and held it in 2 quarters.
  • United Capital Management of KS's Genmab position peaked at $370K in Q1 2026.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on United Capital Management of KS's 13F filing for Q2 2026, filed 5 Aug 2026.